tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Freeman, 10 are a BUY (76.92%), 3 are a HOLD (23.08%).
Analyst Michael Freeman, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 60% that have a potential upside of 39% achieved within 58 days.
Michael Freeman’s has documented 25 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PROF, Profound Medical Corp at 27-Jul-2026.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 12/9/2025. The price target of $21 was fulfilled within 1 day with a profit of $0.31 (1.45%) receiving and performance score of 14.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-Sep-2022
$9
$2.11 (30.62%)
$10
Hold Since 25-Feb-2026
$7
$0.11 (1.60%)
$8
Hold Since 25-Jul-2024
$8
$1.11 (16.11%)
$7
Hold Since 10-Jul-2024
$8
$1.11 (16.11%)
Hold Since 22-Jan-2021
$3
$-3.89 (-56.46%)
Which stock is Michael Freeman is most bullish on?
What Year was the first public recommendation made by Michael Freeman?
